Utility of C-Reactive Protein Levels for Early Prediction of Dengue Severity in Adults

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Chen, Chien Chih ^a   Lee, Ing Kit ^a,b   Liu, Jien Wei ^a,b   Huang, Shi Yu ^a   Wang, Lin ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DENGUE; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; WORLD HEALTH ORGANIZATION; BLOOD; PROGNOSIS; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX;

ADULT; BIOMARKERS; C-REACTIVE PROTEIN; DENGUE; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84938267964     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/936062     Document Type: Article

References (28)

1. C. P. Simmons, J. J. Farrar, N. van Vinh Chau, and B. Wills, "Dengue, " The New England Journal of Medicine, vol. 366, no. 15, pp. 1423-1432, 2012.
2. World Health Organization, Dengue Hemorrhagic Fever: Diagnosis, Treatment and Control, World Health Organization, Geneva, Switzerland, 1997.
3. J. L. Deen, E. Harris, B. Wills et al., "The WHO dengue classification and case definitions: time for a reassessment, " The Lancet, vol. 368, no. 9530, pp. 170-173, 2006.
4. S. Bandyopadhyay, L. C. S. Lum, and A. Kroeger, "Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever, " TropicalMedicine and International Health, vol. 11, no. 8, pp. 1238-1255, 2006.
5. World Health Organization, Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control, WorldHealth Organization, Geneva, Switzerland, 2009.
6. I.-K. Lee, J.-W. Liu, and K. D. Yang, "Clinical and laboratory characteristics and risk factors for fatality in elderly patients with dengue hemorrhagic fever, " American Journal of Tropical Medicine and Hygiene, vol. 79, no. 2, pp. 149-153, 2008.
7. I.-K. Lee, J.-W. Liu, and K. D. Yang, "Fatal dengue hemorrhagic fever in adults: emphasizing the evolutionary pre-fatal clinical and laboratory manifestations, " PLoS Neglected Tropical Diseases, vol. 6, no. 2, Article ID e1532, 2012.
8. T.-L. Thein, V. C. Gan, D. C. Lye, C.-F. Yung, and Y.-S. Leo, "Utilities and limitations of the World Health Organization 2009 warning signs for adult dengue severity, " PLoS Neglected Tropical Diseases, vol. 7, no. 1, Article ID e2023, 2013.
9. J. A. Potts, R. V. Gibbons, A. L. Rothman et al., "Prediction of dengue disease severity among pediatricThai patients using early clinical laboratory indicators, " PLoS Neglected Tropical Diseases, vol. 4, no. 8, article e769, 2010.
10. V. J. Lee, D. C. Lye, Y. Sun, and Y. S. Leo, "Decision tree algorithm in deciding hospitalization for adult patients with dengue haemorrhagic fever in Singapore, " Tropical Medicine and International Health, vol. 14, no. 9, pp. 1154-1159, 2009.
11. H. Gewurz, "Biology of C-reactive protein and the acute phase response, " Hospital Practice, vol. 17, no. 6, pp. 67-81, 1982.
12. M. B. Pepys and G. M. Hirschfield, "C-reactive protein: a critical update, " Journal of Clinical Investigation, vol. 111, no. 12, pp. 1805-1812, 2003.
13. B. Clyne and J. S. Olshaker, "TheC-reactive protein, "TheJournal of Emergency Medicine, vol. 17, no. 6, pp. 1019-1025, 1999.
14. D. L. Jaye and K. B. Waites, "Clinical applications of C-reactive protein in pediatrics, " The Pediatric Infectious Disease Journal, vol. 16, no. 8, pp. 735-747, 1997.
15. L. Epelboin, C. Boullé, S. Ouar-Epelboin et al., "Discriminating malaria from dengue fever in endemic areas: clinical and biological criteria, prognostic score and utility of the C-reactive protein: a retrospective matched-pair study in French Guiana, " PLoS Neglected Tropical Diseases, vol. 7, no. 9, Article ID e2420, 2013.
16. L. Á Villar-Centeno, A. Lozano-Parra, D. Salgado-Garcá, and O. F. Herrán, "Biochemical alterations as prediction markers for the severity of illness in dengue fever patients, " Biomedica, vol. 33, no. 1, pp. 63-69, 2013.
17. P.-Y. Shu, S.-F. Chang, Y.-C. Kuo et al., "Development of groupand serotype-specific one-step SYBR Green I-based real-time reverse transcription-PCR assay for dengue virus, " Journal of Clinical Microbiology, vol. 41, no. 6, pp. 2408-2416, 2003.
18. P.-Y. Shu, L.-K. Chen, S.-F. Chang et al., "Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections, " Clinical and Diagnostic Laboratory Immunology, vol. 10, no. 4, pp. 622-630, 2003.
19. A. Chuansumrit, W. Chaiyaratana, V. Pongthanapisith, K. Tangnararatchakit, S. Lertwongrath, and S. Yoksan, "The use of dengue nonstructural protein 1 antigen for the early diagnosis during the febrile stage in patients with dengue infection, " Pediatric Infectious Disease Journal, vol. 27, no. 1, pp. 43-48, 2008.
20. P.-Y. Shu, C.-F. Yang, J.-F. Kao et al., "Application of the dengue virus NS1 antigen rapid test for on-site detection of imported dengue cases at airports, " Clinical and Vaccine Immunology, vol. 16, no. 4, pp. 589-591, 2009.
21. S. Otsuji, H. Shibata, and M. Umeda, "Turbidimetric immunoassay of serum C-reactive protein, " Clinical Chemistry, vol. 28, no. 10, pp. 2121-2124, 1982.
22. C. P. Price, A. K. Trull, D. Berry, and E. G. Gorman, "Development and validation of a particle-enhanced turbidimetric immunoassay for C-reactive protein, " Journal of Immunological Methods, vol. 99, no. 2, pp. 205-211, 1987.
23. S. Sanders, A. Barnett, I. Correa-Velez, M. Coulthard, and J. Doust, "Systematic review of the diagnostic accuracy of Creactive protein to detect bacterial infection in non-hospitalized infants and children with fever, " Journal of Pediatrics, vol. 153, no. 4, pp. 570-574. e3, 2008.
24. R. G. Flood, J. Badik, and S. C. Aronoff, "The utility of serumCreactive protein in differentiating bacterial from non-bacterial pneumonia in children: a meta-analysis of 1230 children, " The Pediatric Infectious Disease Journal, vol. 27, no. 2, pp. 95-99, 2008.
25. D. Jupe, "The acute phase response and laboratory testing, " Australian Family Physician, vol. 25, no. 3, pp. 324-329, 1996.
26. J. Stuart and J. T. Whicher, "Tests for detecting and monitoring the acute phase response, " Archives of Disease in Childhood, vol. 63, no. 2, pp. 115-117, 1988.
27. F. Narvaez, G. Gutierrez, M. A. Pérez et al., "Evaluation of the traditional and revised WHO classifications of dengue disease severity, " PLoS Neglected Tropical Diseases, vol. 5, no. 11, Article ID e1397, 2011.
28. C. Gabay and I. Kushner, "Acute-phase proteins and other systemic responses to inflammation, "The New England Journal of Medicine, vol. 340, no. 6, pp. 448-454, 1999.